These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25053588)

  • 1. Type 2 diabetes, skin autofluorescence, and brain atrophy.
    Moran C; Münch G; Forbes JM; Beare R; Blizzard L; Venn AJ; Phan TG; Chen J; Srikanth V
    Diabetes; 2015 Jan; 64(1):279-83. PubMed ID: 25053588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus.
    Mulder DJ; de Boer JF; Graaff R; de Vries R; Annema W; Lefrandt JD; Smit AJ; Tietge UJ; Dullaart RP
    Atherosclerosis; 2011 Sep; 218(1):102-6. PubMed ID: 21665206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study.
    Wang X; Zhao X; Lian T; Wei J; Yue W; Zhang S; Chen Q
    BMC Endocr Disord; 2021 Apr; 21(1):58. PubMed ID: 33794864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus.
    Chen J; Zhang J; Liu X; Wang X; Xu X; Li H; Cao B; Yang Y; Lu J; Chen Z
    Eur Radiol; 2017 Oct; 27(10):4247-4256. PubMed ID: 28374074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.
    Yasuda M; Shimura M; Kunikata H; Kanazawa H; Yasuda K; Tanaka Y; Konno H; Takahashi M; Kokubun T; Maruyama K; Sato N; Kakizaki M; Sato M; Tsuji I; Miyata T; Nakazawa T
    Curr Eye Res; 2015 Mar; 40(3):338-45. PubMed ID: 24871684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes.
    Wisse LE; de Bresser J; Geerlings MI; Reijmer YD; Portegies ML; Brundel M; Kappelle LJ; van der Graaf Y; Biessels GJ; ;
    J Neurol Sci; 2014 Sep; 344(1-2):32-6. PubMed ID: 24958596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study.
    Spauwen PJ; van Eupen MG; Köhler S; Stehouwer CD; Verhey FR; van der Kallen CJ; Sep SJ; Koster A; Schaper NC; Dagnelie PC; Schalkwijk CG; Schram MT; van Boxtel MP
    J Clin Endocrinol Metab; 2015 Mar; 100(3):951-60. PubMed ID: 25459912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products in the skin are enhanced in COPD.
    Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
    Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People.
    Igase M; Ohara M; Igase K; Kato T; Okada Y; Ochi M; Tabara Y; Kohara K; Ohyagi Y
    J Alzheimers Dis; 2017; 55(4):1481-1487. PubMed ID: 27858716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of skin autofluorescence measurement over 6 and 12 weeks and the influence of benfotiamine treatment.
    Stirban A; Pop A; Fischer A; Heckermann S; Tschoepe D
    Diabetes Technol Ther; 2013 Sep; 15(9):733-7. PubMed ID: 23964994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.
    de Ranitz-Greven WL; Bos DC; Poucki WK; Visser GH; Beulens JW; Biesma DH; de Valk HW
    Diabetes Technol Ther; 2012 Jan; 14(1):43-9. PubMed ID: 21875328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.
    Jongen C; van der Grond J; Kappelle LJ; Biessels GJ; Viergever MA; Pluim JP;
    Diabetologia; 2007 Jul; 50(7):1509-16. PubMed ID: 17492428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes.
    de Bresser J; Reijmer YD; van den Berg E; Breedijk MA; Kappelle LJ; Viergever MA; Biessels GJ;
    Dement Geriatr Cogn Disord; 2010; 30(5):381-6. PubMed ID: 20962529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus.
    Liu H; Wang G; Wu T; Hu J; Mu Y; Gu W
    J Diabetes; 2022 Sep; 14(9):571-585. PubMed ID: 36058895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population.
    Isami F; West BJ; Nakajima S; Yamagishi SI
    J Int Med Res; 2018 Mar; 46(3):1043-1051. PubMed ID: 29322837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
    Smit AJ; Gerrits EG
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):527-33. PubMed ID: 20844429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.
    Moran C; Phan TG; Chen J; Blizzard L; Beare R; Venn A; Münch G; Wood AG; Forbes J; Greenaway TM; Pearson S; Srikanth V
    Diabetes Care; 2013 Dec; 36(12):4036-42. PubMed ID: 23939539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.